Biosergen AS (BIOSGN) — Financial Flexibility Index
Latest as of December 2025:
-0.59x
Biosergen AS (BIOSGN) has a Financial Flexibility Index of -0.59x as of December 2025. Free cash flow of Skr-7.75 Million (operating CF Skr-7.75 Million minus capex Skr0.00) represents -1% of total liabilities (Skr13.04 Million).
Financial Flexibility Index
-0.59x
Free Cash Flow / Total Liabilities
Free Cash Flow
Skr-7.75 Million
Operating CF − Capex
Total Liabilities
Skr13.04 Million
SEK
Capital Expenditures
Skr0.00
SEK
Biosergen AS Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Biosergen AS across 7 annual periods. See Biosergen AS current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biosergen AS (2019–2025)
Year-by-year free cash flow to debt coverage for Biosergen AS. For the full company profile including market capitalisation, see BIOSGN market cap overview.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.73x | Skr-35.53 Million | Skr-35.53 Million | Skr13.04 Million | ▲ +39.2% |
| 2024 | -4.48x | Skr-16.63 Million | Skr-16.63 Million | Skr3.71 Million | ▲ +30.1% |
| 2023 | -6.41x | Skr-32.60 Million | Skr-32.60 Million | Skr5.08 Million | ▼ -139.5% |
| 2022 | -2.68x | Skr-29.44 Million | Skr-29.44 Million | Skr11.00 Million | ▲ +34.4% |
| 2021 | -4.08x | Skr-37.75 Million | Skr-37.75 Million | Skr9.25 Million | ▼ -1299.1% |
| 2020 | -0.29x | Skr-4.58 Million | Skr-4.58 Million | Skr15.72 Million | ▼ -43.2% |
| 2019 | -0.20x | Skr-2.31 Million | Skr-2.31 Million | Skr11.37 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities